CYCC Bio Green Med Solution Inc.


$ 1.26 $ 0.03 (2.36 %)    

Thursday, 20-Nov-2025 12:58:02 EST
QQQ $ 594.53 $ -17.14 (-2.8 %)
DIA $ 460.82 $ -5.86 (-1.26 %)
SPY $ 659.64 $ -13.26 (-1.98 %)
TLT $ 89.14 $ 0.15 (0.17 %)
GLD $ 373.35 $ -1.83 (-0.49 %)
$ 1.29
$ 1.27
$ 1.25 x 17
$ 1.27 x 100
$ 1.30 - $ 1.30
$ 1.19 - $ 101.30
42,638
na
na
$ 1.29
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 cyclacel-pharmaceuticals-exchanges-series-c-warrants-for-559395-common-shares-in-agreement-with-accredited-investors

On September 4, 2025, Cyclacel Pharmaceuticals, Inc. (the "Company") entered into a Warrant Exchange Agreement (the ...

 cyclacel-pharmaceuticals-stock-up-346-in-massive-after-hours-rally

After sharing encouraging preclinical results for a potential biliary tract cancer treatment, Cyclacel Pharmaceuticals jumped 3...

 reported-earlier-cyclacel-announces-new-findings-supporting-use-of-plogosertib-in-biliary-tract-cancer-patients-with-high-bubr1-expression

  Biliary tract cancer (BTC) or cholangiocarcinoma is an aggressive tumor with poor prognosis 

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION